General MedicationsINJECTIONStandard
EPTIFIBATIDE
EPTIFIBATIDE
Standard Dose
2MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview EPTIFIBATIDE is listed in Drugs@FDA under application 213599 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient EPTIFIBATIDE Form and strength INJECTABLE;INJECTION - 2MG/ML Sponsor MEITHEAL Submission history Latest submission status date: 2024-05-09 00:00:00.
Structured Monograph
Clinical summary
Approval overview EPTIFIBATIDE is listed in Drugs@FDA under application 213599 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient EPTIFIBATIDE Form and strength INJECTABLE;INJECTION - 2MG/ML Sponsor MEITHEAL Submission history Latest submission status date: 2024-05-09 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.